San Francisco, California, May 16, 2018 – TMR Research’s new publication, titled “Female Pelvic Implants Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025,” provides in-depth analysis of the female pelvic implants market. It examines demand drivers, trends, and technological advances that could have a bearing on the market’s growth over the 2017 – 2025 forecast timeframe. North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa are the regions examined to comprehend the growth of worldwide female pelvic implants market.
The rising demand for a value based healthcare model is predicted to act in favor of the global female pelvic implants market. Several regulatory bodies and governments worldwide are encouraging cost-containment to serve the need to reduce healthcare costs and burden.
Female pelvic implants are used to treat certain disorders among women such as pelvic organ prolapse and stress urinary incontinence. These vaginal disorders are usually prevalent in aged women that impacts their everyday life due to discomfort. Female pelvic implants mostly used are vaginal grafts, vaginal tapes, vaginal mesh implants, and vaginal slings. Vaginal slings are anticipated to be most attractive in terms of market share until 2025. Vaginal slings have been commercially available for about 20 years and involve minimally invasive surgical procedure.
Get Sample Copy of this Report @
Increasing number of complications in implant procedures and failure of female pelvic implant are some factors having a negative impact on the female pelvic implants market. As per data from NHS, since 2011, thousands of women in the U.K. have undergone reverse surgery for removal of vaginal mesh.
In terms of product, the female pelvic implant market is segmented into absorbable synthetic, non-absorbable synthetic, biologic, and composite. By end-use, hospitals and ambulatory surgical centers are the segments into which the female pelvic implants market is divided.
Key companies to name in the female pelvic implants market include Acumed LLC, Pfm Medical, C.R. Bard, Ethicon, DePuy Synthes, Stryker, and Coloplast.